ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis

Blood. 2015 Nov 12;126(20):2344-5. doi: 10.1182/blood-2015-07-655530. Epub 2015 Oct 5.

Authors

Ryanne A Brown¹, Bernice Y Kwong², Timothy H McCalmont³, Bruce Ragsdale⁴, Lisa Ma¹, Christine Cheung¹, Kerri E Rieger⁵, Daniel A Arber¹, Jinah Kim⁵

Affiliations

¹ Department of Pathology, Stanford University School of Medicine, Stanford, CA.
² Department of Dermatology, Stanford University School of Medicine, Stanford, CA.
³ Departments of Pathology and Dermatology, Dermatopathology Service, University of California at San Francisco, San Francisco, CA.
⁴ Western Pathology, Inc, San Luis Obispo, CA.
⁵ Departments of Pathology and Dermatology, Stanford University School of Medicine, Stanford, CA.

PMID: 26438513
DOI: 10.1182/blood-2015-07-655530

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Female
Histiocytosis* / genetics
Histiocytosis* / metabolism
Histiocytosis* / pathology
Humans
Male
Middle Aged
Nuclear Receptor Coactivator 2* / genetics
Nuclear Receptor Coactivator 2* / metabolism
Proto-Oncogene Proteins c-ets* / genetics
Proto-Oncogene Proteins c-ets* / metabolism

Substances

ETV3 protein, human
NCOA2 protein, human
Nuclear Receptor Coactivator 2
Proto-Oncogene Proteins c-ets